-
Valneva to Provide SARS-CoV-2 Vax Candidate to UK Govt
contractpharma
July 21, 2020
Valneva's VLA2001, an inactivated whole virus vaccine candidate against coronavirus is expected to enter clinical studies by the end of 2020.
-
Seven Indian pharmaceutical companies race to develop vaccine for deadly coronavirus
expresspharma
July 20, 2020
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
-
US fast tracks Pfizer/BioNTech coronavirus vaccines
pharmatimes
July 17, 2020
US regulators have fast-tracked Pfizer and BioNTech's novel coronavirus vaccine candidates BNT162b1 and BNT162b2.
-
Greater global cooperation needed to tackle vaccine-preventable diseases in a world with COVID-19
expresspharma
July 17, 2020
The authors of the study also included researchers at the University of Ghana, Imperial College London, the Center for Global Development Europe, London School of Hygiene & Tropical Medicine and the University of Cambridge.
-
Swiftly waning COVID-19 immunity poses vaccination challenge
expresspharma
July 16, 2020
Preliminary studies in China, Germany, Britain and elsewhere have found that patients infected with the novel coronavirus make protective antibodies as part of their immune system’s defences, but these appear to last only a few months.
-
Moderna Phase 1 results show coronavirus vaccine safe, induces immune response
expresspharma
July 16, 2020
Volunteers who got two doses of the vaccine had high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from COVID-19: Moderna's research team.
-
Operation Warp Speed to start making COVID-19 vaccine by end of summer, says U.S. official
expresspharma
July 15, 2020
He added that the administration is already working with companies to equip and outfit manufacturing facilities and acquire raw materials.
-
Bill Gates calls for COVID-19 meds to go to people who need them, not ‘highest bidder’
expresspharma
July 13, 2020
Billionaire philanthropist Bill Gates called for COVID-19 drugs and an eventual vaccine to be made available to countries and people that need them most, not to the “highest bidder,” saying relying on market forces would prolong the deadly pandemic.
-
Further billions pledged to ensure equitable access to COVID-19 treatments
europeanpharmaceuticalreview
July 03, 2020
The European Investment Bank (EIB), in partnership with the European Commission (EC), have pledged an additional €4.9 billion for use in the global coronavirus response funds.
-
Chinese firm says coronavirus vaccine candidate shows promise in human test
expresspharma
June 30, 2020
The experimental shot, developed by a Beijing-based unit of CNBG, has induced high-level antibodies in all the inoculated participants in a Phase 1/2 clinical trial involving 1,120 healthy people.